Publication NumberUS 7482331
Assignees
  • The Regents of the University of Colorado
StatusIssued Patent
Application Number09/558472
AvailabilityLicensable
Filing Date2000-04-25
Publication Date2009-01-27

Abstract

The invention provides a method of treating myocardial failure in a human. The method comprises administering an effective amount of transgene encoding α-MHC that directly causes an increase in the quantity of α-MHC in the myocardial tissue of the heart.

Claims

  • 1. A method of treating myocardial failure in a human comprising administering an effective amount of a transgene encoding for α-MHC, wherein expression of α-MHC provides improvement in left ventricular ejection fraction.